Recent Finacing
Recent Raise
Fuse Biotherapeutics is a biotechnology company developing NK‑cell–focused immune‑modulating therapeutics and a proprietary platform to direct innate and adaptive responses for targeted cancer treatment while minimizing healthy tissue damage.
